← Leaderboards
Jeffrey P Baker
Duke University
$358,143
Attributed
$358,143
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$358,143 · 2
By mechanism
G13$215,235 · 1
F32$142,908 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Jack D Keene$4,464,304
- Herbert Kim Lyerly$48,598,090
- Kevin C Olbrich$444,014
- Teresa Borras$11,519,592
- Kenneth G. Manton$25,808,973
Others in their field
Top investigators on “Stress Proteins”
- John Morris · Washington University$31,258,321
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$29,877,036
- Carol Prives · Icahn School Of Medicine At Mount Sinai$29,200,065
- Shi Du Yan · Columbia University Health Sciences$29,185,319
- Robert O Wright · Brigham And Women'S Hospital$29,180,944
- Kathy K Griendling · Emory University$28,908,643
Research focus
Stress ProteinsAdenosine DiphosphateAdenosine TriphosphateAffinity ChromatographyAntineoplasticsBehavioral /Social Science Research TagBinding ProteinsBinding SitesCalorimetryCell LineHealth /Scientific OrganizationMembrane ProteinsMolecular ChaperonesPharmacokineticsPoint MutationPostdoctoral InvestigatorProtein Protein InteractionProtein Structure FunctionProtein TransportStoichiometryChimeric ProteinsDimerDisease /Disorder Prevention /ControlDrug Discovery /Isolation
Grant awards (6)
Childhood Vaccine Policy in the U.S. Since 1955$70,025
G13 · FY2005 · LM
Childhood Vaccine Policy in the U.S. Since 1955$70,943
G13 · FY2004 · LM
Regulation of GRP94: Targeting Novel Cancer Therapeutics$50,548
F32 · FY2004 · CA
Childhood Vaccine Policy in the U.S. Since 1955$74,267
G13 · FY2003 · LM
Regulation of GRP94: Targeting Novel Cancer Therapeutics$48,148
F32 · FY2003 · CA
Regulation of GRP94: Targeting Novel Cancer Therapeutics$44,212
F32 · FY2002 · CA